id.almeida

TL2 Moderator · Wrocław

Contributes reviews on supplier material. Based in Wrocław.

Joined 15 February 2025 · last posted 2d

80 posts, newest first. Showing up to 150.

[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #72 · Analytics › HPLC & UHPLC · 26 Jul 2026 · 24 likes On post #68 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #51 · Compounds › Secretagogues & GH axis · 24 Jul 2026 · 0 likes Why this subcategory is stricter about sourcing than most: the evidence base is weaker and that is precisely why documentation quality matters more. A supplier page…
Reading order for a first week here, and what to skip until later — what changed since Replied, post #43 · Start Here › Welcome · 14 Jul 2026 · 0 likes There is no stupid-questions rule and no penalty for asking badly. The response to a poorly framed question is a request for clarification, not rudeness. That is a…
HbA1c lag and what it can and cannot tell you at eight weeks — one year on Replied, post #18 · Clinical › Bloodwork · 11 Jul 2026 · 15 likes post #17 answers the question as asked. The question underneath it is different. Analytical imprecision: any measurement has an error margin. A small difference in…
Coming back to: Batch date after test date, and other internal inconsistencies Replied, post #9 · Analytics › COA interpretation · 11 Jul 2026 · 0 likes When a document puts the specification in the result column, it has told you the release criterion, not the measurement. Those are different claims and the second is…
Second pass at: When your prescriber and the evidence disagree Replied, post #47 · Clinical › Prescriber conversations · 8 Jul 2026 · 0 likes Clarifying indication: if a compound is approved for diabetes but you have obesity without diabetes, clarify whether your clinician considers this off-label use and…
Why a pen's dose steps are fixed and what that costs you Replied, post #3 · Devices › Pens & autoinjectors · 6 Jul 2026 · 11 likes Visibility of the dose: some pens allow you to see the insulin remaining; others do not. Keeping track using the dose counter is important if visibility is limited.
Personal or family history of medullary thyroid carcinoma Replied, post #34 · Safety › Contraindications · 1 Jul 2026 · 5 likes On post #30 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
What a certificate commits its issuer to — one year on Replied, post #99 · Analytics › COA interpretation · 30 Jun 2026 · 10 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #32 · Analytics › Impurities & related substances · 28 Jun 2026 · 11 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #49 · Compounds › Repair & healing peptides · 27 Jun 2026 · 1 like post #48 answers the question as asked. The question underneath it is different. The absence of adequately powered published randomised human trials is the central fact…
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #129 · Practice › Storage & stability · 10 Jun 2026 · 0 likes Published stability data applies specifically to the formulation studied, under the specific conditions stated. It does not automatically transfer to something…
Second pass at: Absence of evidence and evidence of absence Replied, post #18 · Research Methods › Statistics · 9 Jun 2026 · 14 likes Number needed to treat: how many people need to be treated to prevent one bad outcome or achieve one good outcome. More intuitive than relative risk reduction.
Trust level 3 requirements: a clarification — does this still hold? Replied, post #59 · Meta › Announcements · 5 Jun 2026 · 22 likes On post #55 — agreed on the reasoning, with one qualification. Staff announcements, policy changes, and scheduled maintenance. Read-only except for questions clarifying…
Peak-to-trough ratio at steady state for a weekly agent Replied, post #10 · Pharmacology › Pharmacokinetics · 30 May 2026 · 31 likes Individual variation: people vary in how quickly they absorb, distribute, metabolise, and excrete these compounds. That variation is partly genetic and partly due to…
The anatomy of a question that gets answered within an hour Replied, post #52 · Start Here › How to Ask · 21 May 2026 · 8 likes Asking a follow-up: new topic or reply in the old one? If the answer depends on the previous post, reply. If it is a question that makes sense without the previous…
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #62 · Practice › Reconstitution · 20 May 2026 · 0 likes The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL is the most common arithmetic error in this subcategory. The habit that catches it:…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — a second dataset Replied, post #44 · Sourcing › Independent verification · 6 May 2026 · 3 likes When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation review, that is not a negative finding about the product. It…
Follow-up: State-level differences that actually matter Replied, post #45 · Regional › North America · 6 Apr 2026 · 15 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
The "under review" status pill and when a moderator applies it Replied, post #17 · Evidence › Preprints · 12 Mar 2026 · 0 likes Worth separating two things that post #13 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
The lowest dose that does anything: is that a real question? Replied, post #110 · Practice › Dosing & titration · 8 Mar 2026 · 0 likes Steady state means the plasma concentration is stable from dose to dose. That happens around 4 to 5 half-lives. Before that, the concentration is rising with each dose.…
Pregnancy and pregnancy planning: contraindication and washout Replied, post #56 · Clinical › Special populations · 27 Feb 2026 · 18 likes Pregnancy and planning: these compounds are not approved for use in pregnancy. Planning windows (how long to wait before attempting pregnancy) are not formally…
Non-inferiority margins: how they are chosen and how they are abused — a second dataset Replied, post #37 · Evidence › Trials · 24 Feb 2026 · 21 likes Surrogate endpoints: an endpoint that is not the outcome that matters but is measured as a stand-in. HbA1c is a surrogate for long-term glucose control and the…
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #68 · Practice › Dosing & titration · 18 Feb 2026 · 0 likes Steady state means the plasma concentration is stable from dose to dose. That happens around 4 to 5 half-lives. Before that, the concentration is rising with each dose.…
Amylin receptor signalling and satiety — what changed since Replied, post #32 · Pharmacology › Receptor biology · 18 Feb 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Second pass at: Metformin co-administration and additive GI effects Replied, post #49 · Practice › Interactions · 13 Feb 2026 · 0 likes Picking up post #46: that is the part I would want checked first. Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the…
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #66 · Compounds › Semaglutide · 11 Feb 2026 · 5 likes The SELECT trial changed the positioning because it was the first cardiovascular outcome trial in people without diabetes. That decoupled the cardiovascular argument…
Trust level 3 requirements: a clarification — does this still hold? Replied, post #3 · Meta › Announcements · 7 Feb 2026 · 1 like post #2 is right about the mechanism and I think understates the practical bit. Notifications: watching this subcategory means you receive notifications when…
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #86 · Clinical › Special populations · 25 Jan 2026 · 0 likes Picking up post #83: that is the part I would want checked first. Adolescents: a distinct evidence base exists. The compounds are not approved for routine adolescent…
MHRA statements, read directly Replied, post #65 · Regional › UK & Ireland · 10 Jan 2026 · 15 likes Worth separating two things that post #61 runs together. Regional variation in NHS: access varies dramatically by region depending on local commissioning decisions and…
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #47 · Clinical › Bloodwork · 9 Jan 2026 · 32 likes post #46 answers the question as asked. The question underneath it is different. Lipid panel interpretation: total, LDL, HDL, triglycerides all on one panel. Reading…
Personal import allowances, compared — a second dataset Replied, post #45 · Access › International · 2 Jan 2026 · 2 likes Customs and import outcomes: different routes have different seizure rates. Some countries are stricter on peptide imports than others. History on a route is more…
A pen that felt like it delivered nothing: diagnosing it afterwards Replied, post #32 · Devices › Pens & autoinjectors · 11 Dec 2025 · 31 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Heterogeneity as information rather than as a nuisance Replied, post #21 · Evidence › Meta-analyses · 10 Dec 2025 · 30 likes This follows post #18 rather than contradicting it. Pooled estimates and heterogeneity: when trials differ in population, duration, or comparator, a pooled estimate…
Coming back to: Injection-site reactions: describing them precisely enough to be useful Replied, post #24 · Practice › Side effects · 25 Nov 2025 · 5 likes I read post #22 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
What pooling buys you and what it destroys Replied, post #74 · Evidence › Meta-analyses · 24 Nov 2025 · 0 likes I read post #72 twice before replying, because I had assumed the opposite. Study quality and weighting: some meta-analyses weight all studies equally; others weight by…
Follow-up: Sodium, potassium and magnesium when intake drops Replied, post #10 · Nutrition & Training › Hydration & electrolytes · 21 Nov 2025 · 20 likes Constipation and hydration: dehydration makes constipation worse. Increasing fluid intake is the first intervention for constipation alongside other measures.
Coverage in the US: a map of the usual obstacles Replied, post #13 · Regional › North America · 20 Nov 2025 · 4 likes Prior authorisation, step therapy, and exclusion of weight-management indications from coverage are common access barriers. The denial letter tells you which barrier…
Pen dose counters: what a click does and does not guarantee Replied, post #120 · Devices › Pens & autoinjectors · 20 Nov 2025 · 0 likes On post #116 — agreed on the reasoning, with one qualification. Storage after first use: most pens can be stored at room temperature after first use, even if…
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #90 · Sourcing › Vendor reports · 12 Nov 2025 · 25 likes Structured report format: compound, lot, independent testing service, method as reported, result, and the certificate figure for the same lot. One lot is one lot. It…
Second pass at: The mass-error checker and its intended scope Replied, post #45 · Data & Tools › Calculators · 23 Oct 2025 · 0 likes Offline use: all calculators are written in JavaScript and can be downloaded and run offline if desired. They do not require internet connectivity to function.
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #119 · Access › Insurance & coverage · 14 Sep 2025 · 9 likes Picking up post #116: that is the part I would want checked first. Out-of-pocket costs: if insurance is not covering it, asking about patient assistance programmes run…
A ten-fold dose error caught before injection Replied, post #97 · Devices › Syringes & needles · 9 Sep 2025 · 0 likes Dead volume: residual liquid in the hub and needle after withdrawal. Typical residual is 0.01 to 0.02 mL for an insulin syringe with a fixed needle. Accounting for it…
Pooling trials with different estimands — what changed since Replied, post #19 · Evidence › Meta-analyses · 31 Aug 2025 · 0 likes This follows post #16 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
Journal club: STEP-HFpEF and symptom endpoints — a second dataset Replied, post #5 · Evidence › Journal club · 28 Aug 2025 · 9 likes SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people without diabetes, which decoupled the cardiovascular…
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #54 · Evidence › Journal club · 28 Aug 2025 · 0 likes post #53 is right about the mechanism and I think understates the practical bit. SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight…
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #46 · Practice › Reconstitution · 22 Aug 2025 · 4 likes Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin syringe, you need a concentration high enough that 0.25 mg fits on the scale. A 0.25…
Why catalogue breadth is not evidence of anything — what changed since Replied, post #18 · Compounds › Other compounds · 13 Aug 2025 · 19 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Revisiting: List price versus negotiated price versus what you pay Replied, post #3 · Access › Pricing · 2 Aug 2025 · 1 like On the opening post — agreed on the reasoning, with one qualification. Cost per milligram is the only comparison that survives format differences, but even then it…
Coming back to: What published stability data actually covers, and what it does not Replied, post #102 · Practice › Storage & stability · 1 Aug 2025 · 20 likes I read post #100 twice before replying, because I had assumed the opposite. Beyond-use dating: the date after which a prepared solution should not be used. It is an…
High-resolution MS on aggregates and what it can see Replied, post #30 · Analytics › Mass spectrometry · 26 Jul 2025 · 27 likes Common adducts: sodium adds ≈22, potassium adds ≈38 compared to hydrogen. A [M+Na]+ peak is common and its mass is predictable from the base mass.
Coming back to: Oxidation and deamidation mass shifts, tabulated Replied, post #19 · Analytics › Mass spectrometry · 7 Jul 2025 · 11 likes Mass accuracy is expressed in parts per million. It is the difference between observed and theoretical mass divided by theoretical mass, multiplied by a million. A…
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #58 · Compounds › Cagrilintide & amylin analogues · 21 Jun 2025 · 14 likes post #57 is right about the mechanism and I think understates the practical bit. Cagrilintide alone is discussed less than in combination because the published data is…
Repeatability versus intermediate precision Replied, post #21 · Analytics › Method validation · 20 Jun 2025 · 0 likes Linearity: the detector response is proportional to compound concentration across the working range. Demonstrated by running standards at multiple concentrations and…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #110 · Compounds › Tirzepatide · 14 Jun 2025 · 19 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Reconstituting a multi-strength kit without mixing yourself up Replied, post #84 · Practice › Reconstitution · 11 Jun 2025 · 0 likes post #83 is right about the mechanism and I think understates the practical bit. Choosing a concentration on purpose rather than by accident: starting with "I want to…
A claim built entirely on a subgroup analysis Replied, post #55 · Evidence › Study critique · 25 May 2025 · 16 likes Defending a paper against criticism: if the authors respond, they might clarify something the paper explained poorly. Their response might also miss your point. Either…
Second pass at: Designing a personal experiment that could change your mind Replied, post #17 · Research Methods › N-of-1 designs · 18 May 2025 · 0 likes Picking up post #14: that is the part I would want checked first. Stopping rules: decide in advance when you will stop measuring (after a defined duration, after a…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #95 · Sourcing › Independent verification · 14 May 2025 · 0 likes How to submit a sample: contact the service directly. They will provide instructions on vial type, quantity, labelling, shipping. Following their instructions exactly…
Reconstituting a multi-strength kit without mixing yourself up Replied, post #67 · Practice › Reconstitution · 6 May 2025 · 0 likes I read post #65 twice before replying, because I had assumed the opposite. Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a…
When to stop reading forums, including this one — the long version Replied, post #6 · marked as the solution · Wellbeing › Mental health · 1 May 2025 · 8 likes I read post #4 twice before replying, because I had assumed the opposite. When to involve a professional: if mood changes are persistent, deepen over weeks, or…
When "no data" is the complete and final answer Replied, post #133 · Compounds › Other compounds · 30 Mar 2025 · 3 likes AOD-9604 is a fragment of human growth hormone and has been discussed as a potential weight-loss agent based on theoretical mechanism. The fragment hypothesis — that…
Micronutrient status when intake falls substantially — a second dataset Replied, post #11 · Clinical › Bloodwork · 23 Mar 2025 · 0 likes Reference intervals: constructed to contain the central 95% of a reference population, which means one in twenty healthy people falls outside one by definition. Add…
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #83 · Compounds › Cagrilintide & amylin analogues · 19 Mar 2025 · 4 likes I read post #81 twice before replying, because I had assumed the opposite. Reading the phase 2 paper: it establishes tolerability and efficacy in a selected population…
Validating a method you did not develop — does this still hold? Replied, post #133 · Analytics › Method validation · 18 Mar 2025 · 0 likes Coming back to post #131, because the follow-up matters more than the original answer. System suitability: injections run at the start of a batch to establish that the…
Retatrutide dose escalation in the published trials Replied, post #21 · Compounds › Retatrutide · 17 Mar 2025 · 1 like Mass and identity: a report on retatrutide should state the mass detected by LC-MS, not assume a theoretical mass. The theoretical mass is not published in…
One lot is one lot: when a report becomes a pattern — the long version Replied, post #44 · Sourcing › Vendor reports · 16 Mar 2025 · 15 likes Lot matching: confirm the lot number on the certificate matches the lot number on the vial. A result from a different lot is not evidence about your vial.
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #88 · Compounds › Semaglutide · 5 Mar 2025 · 0 likes The STEP programme populations were selected: enrollment criteria required baseline body mass index over 30, no recent blood pressure crisis, no recent retinopathy, no…
Cost per milligram, computed honestly across formats — the long version Replied, post #21 · Access › Pricing · 1 Mar 2025 · 2 likes Pharmacy acquisition cost: a pharmacy pays less than the patient pays, even at insurance rates. That margin is where the pharmacy's costs and profit live.
How compounding permissions changed when supply normalised Replied, post #24 · Sourcing › Regulatory · 27 Feb 2025 · 21 likes Off-label use and medical practice: clinicians can prescribe approved medications off-label under some circumstances. That is different from research-use-only…
A promotion I argued against, and why I lost Replied, post #71 · Documentation › Doc review · 23 Jan 2025 · 0 likes On post #67 — agreed on the reasoning, with one qualification. Multilingual versions: if a maintained page should exist in another language, suggesting it here with…
[2026 update] Lipid changes during rapid weight loss: the expected trajectory Replied, post #9 · Clinical › Bloodwork · 5 Jan 2025 · 0 likes Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the evening. Comparing results from different times of day is…
Reading a supplementary appendix and finding the interesting part Replied, post #42 · Evidence › Trials · 12 Dec 2024 · 14 likes Open-label design: unblinded trials admit expectation effects. For weight-loss trials where one arm loses substantial weight and the other does not, complete blinding…
Washout with a one-week half-life: the arithmetic Replied, post #94 · Research Methods › N-of-1 designs · 9 Dec 2024 · 0 likes When to run an n-of-1: this design works when you want to know whether a treatment works for you, not whether it works in general. For that purpose, it is efficient.
A revision dispute resolved on the topic rather than in the history — a second dataset Replied, post #47 · Meta › Wiki maintenance · 25 Nov 2024 · 9 likes Authority: if you think a page needs input from someone with specific expertise, suggesting that person helps the maintainer recruit contributors.
EMA product information as a primary source — does this still hold? Replied, post #29 · Regional › European Union · 15 Nov 2024 · 6 likes I read post #27 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
When a red flag was a misunderstanding, and the retraction Replied, post #12 · Sourcing › Red flags · 5 Sep 2024 · 19 likes Safety documentation absent: a supplier that cannot provide information about sterility testing, endotoxin testing, or safety documentation when asked is raising flags.
Circumference measurements as a poor man's composition estimate Replied, post #21 · Outcomes › Body composition · 26 Jul 2024 · 17 likes Changes during titration: measuring body composition during active titration is less useful than measuring after dose is stable. Titration causes fluid shifts that…
Cold packs, phase-change material, and what survives ten days Replied, post #126 · Sourcing › Logistics · 20 Jul 2024 · 14 likes On post #122 — agreed on the reasoning, with one qualification. Declaring contents accurately: declaring accurately reduces intervention risk. A declaration of "peptide…
How this community labels and discusses unrefereed work Replied, post #49 · Evidence › Preprints · 29 Jun 2024 · 0 likes Check whether it was later published: searching for the preprint's first author and keywords in PubMed might find a published version. The published version is the…